The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - MorphoSys
Phase IIa study of single-agent MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL).
 
Wojciech Jurczak
Consulting or Advisory Role - Mundipharma; Novartis; Spectrum Pharmaceuticals; Takeda; Teva
Research Funding - Celgene; Eisai; Gilead Sciences; Janssen; Pfizer; Pharmacyclics; Roche Pharma AG; Sandoz; Spectrum Pharmaceuticals; Takeda; Teva
 
Pier Luigi Zinzani
No Relationships to Disclose
 
Andre Goy
Honoraria - Infinity Pharmaceuticals
Consulting or Advisory Role - Celgene; Johnson & Johnson; Pharmacyclics; Takeda
Speakers' Bureau - Johnson & Johnson; Pharmacyclics; Takeda
Research Funding - Celgene; Johnson & Johnson; Pharmacyclics
 
Mariano Provencio
No Relationships to Disclose
 
Zsolt Nagy
Research Funding - MorphoSys
 
Tadeusz Robak
Research Funding - MorphoSys
 
Kami J. Maddocks
Consulting or Advisory Role - MorphoSys; Pharmacyclics; Seagen
Research Funding - Pharmacyclics
 
Christian Buske
Honoraria - Janssen; Pfizer; Roche Pharma AG
Research Funding - Janssen; Roche Pharma AG
 
Roman Korolkiewicz
No Relationships to Disclose
 
Mark Winderlich
Employment - MorphoSys
Patents, Royalties, Other Intellectual Property - MorphoSys
 
Kristie A. Blum
Research Funding - MorphoSys